Cellivate

Solving bottlenecks faced by cell-based companies at different stages of the value chain

Singapore, Singapore · Founded 2024 · $1.0M raised

Headquarters
Singapore
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$1.0M
Last Round
$1.0M SeedAug 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cellivate Technologies is a National University of Singapore spin-off that develops animal-free, proprietary cell culture products. Its flagship BOOSTER product delivers controlled extracellular vesicle-mediated signaling to replace fetal bovine serum, reducing batch-to-batch variability for pharmaceutical, cultivated meat, cosmetics, and biotech applications.

Summary

Cellivate is a Healthcare company based in Singapore, Singapore, founded in 2024. It has raised $1.0M in total across 1 round, most recently a $1.0M Seed round in Aug 2024. Investors include Venture Catalysts, HATCHER+ and Waterbridge Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundAug 2024
$1.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellivate on Indexed.vc
<a href="https://indexed.vc/companies/cellivate"><img src="https://indexed.vc/api/badge/company/cellivate" alt="Cellivate on Indexed.vc" width="260" height="76" /></a>